全文获取类型
收费全文 | 178805篇 |
免费 | 34196篇 |
国内免费 | 2945篇 |
专业分类
耳鼻咽喉 | 5720篇 |
儿科学 | 5734篇 |
妇产科学 | 2715篇 |
基础医学 | 8018篇 |
口腔科学 | 1943篇 |
临床医学 | 28857篇 |
内科学 | 52939篇 |
皮肤病学 | 8849篇 |
神经病学 | 16878篇 |
特种医学 | 8339篇 |
外国民族医学 | 3篇 |
外科学 | 44663篇 |
综合类 | 535篇 |
现状与发展 | 73篇 |
一般理论 | 10篇 |
预防医学 | 8009篇 |
眼科学 | 4191篇 |
药学 | 3837篇 |
3篇 | |
中国医学 | 564篇 |
肿瘤学 | 14066篇 |
出版年
2024年 | 527篇 |
2023年 | 4915篇 |
2022年 | 1815篇 |
2021年 | 4289篇 |
2020年 | 6631篇 |
2019年 | 3053篇 |
2018年 | 8367篇 |
2017年 | 8117篇 |
2016年 | 9550篇 |
2015年 | 10063篇 |
2014年 | 17373篇 |
2013年 | 17586篇 |
2012年 | 8531篇 |
2011年 | 8368篇 |
2010年 | 12059篇 |
2009年 | 15625篇 |
2008年 | 7582篇 |
2007年 | 5689篇 |
2006年 | 7883篇 |
2005年 | 5093篇 |
2004年 | 3983篇 |
2003年 | 2797篇 |
2002年 | 2833篇 |
2001年 | 4114篇 |
2000年 | 3295篇 |
1999年 | 3437篇 |
1998年 | 3769篇 |
1997年 | 3564篇 |
1996年 | 3429篇 |
1995年 | 3261篇 |
1994年 | 2004篇 |
1993年 | 1599篇 |
1992年 | 1452篇 |
1991年 | 1485篇 |
1990年 | 1120篇 |
1989年 | 1250篇 |
1988年 | 1055篇 |
1987年 | 901篇 |
1986年 | 926篇 |
1985年 | 746篇 |
1984年 | 577篇 |
1983年 | 540篇 |
1982年 | 526篇 |
1981年 | 429篇 |
1980年 | 383篇 |
1979年 | 333篇 |
1978年 | 345篇 |
1977年 | 412篇 |
1975年 | 282篇 |
1972年 | 306篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
91.
92.
93.
94.
95.
96.
97.
98.
K.-C. Sung D.-C. Seo S.-J. Lee M.-Y. Lee S.H. Wild C.D. Byrne 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(5):489-495
Background and aims
It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.Methods and results
As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.Conclusions
In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes. 相似文献99.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
100.